Moderna is one of two drugmakers that announced on Thursday the full results of a closely watched trial of an experimental vaccine given to patients with melanoma.
Nizamiye Hospital in Abuja, Nigeria, where the country’s first Ebola patient was admitted this week. An African health official said that if authorities could not come up with ways to stamp out the outbreak, “the whole continent can be affected.”